ENTPD1 and hepatocellular carcinoma: PD1 resistance and poor prognosis in hepatocellular carcinoma (HCC) patients are associated with the upregulation of CD39 expression in macrophages, and CD39 can be used as a marker of unfavorable prognosis in HCC patients (37).